Comparing ghost stoma to no stoma after rectal cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial compares two ways of managing the bowel after rectal cancer surgery: using a 'ghost stoma' (a temporary loop of intestine placed under the skin but not opened) versus no stoma at all. The goal is to see which approach leads to fewer complications and better recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with rectal cancer.
- You are between 18 and 80 years old.
- During your surgery, your surgeon performed either a 'ghost stoma' (a temporary loop of intestine placed under the skin but not opened) or no stoma at all.
- You do not have severe heart disease, kidney failure, or cirrhosis of the liver.
- You are not taking long-term immunosuppressive drugs or steroids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how different stoma (opening in the belly) approaches affect recovery after curative rectal cancer surgery. It may help doctors choose the safest, most comfortable option for bowel function and healing after surgery.
This trial compares two types of temporary stomas (a bag on the belly to collect stool) after rectal cancer surgery. It aims to see which type—ileostomy (small intestine) or colostomy (large intestine)—works better for patients.
This trial tests whether a temporary stoma (a bag on the belly) can be safely avoided in some people having rectal cancer surgery. The goal is to see if it's okay to skip the stoma in those with a low risk of complications.
This trial compares two ways of doing rectal cancer surgery: one with a temporary stoma (a bag on the belly) and one without. It aims to see if a stoma helps prevent complications after the bowel is reconnected.
This trial tests whether using a medication called somatostatin plus a clear liquid diet can safely prevent serious complications after surgery to remove rectal cancer, without needing a temporary opening in the abdomen (stoma). You'll be randomly assigned to receive either somatostatin with diet changes or a stoma, depending on your individual risk factors.
This trial compares two ways to protect the healing connection in your bowel after rectal cancer surgery. One method uses a thin tube placed through your nose down to the small intestine to divert stool away from the surgery site before the operation, while the other creates a temporary opening in the abdomen (an ileostomy) during the surgery. The goal is to see if the tube works as well as the ileostomy in preventing leaks and improving recovery.
Hear when a new Rectal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.